Cytoplasmic RNA Sensor Pathways and Nitazoxanide Broadly Inhibit Intracellular Mycobacterium tuberculosis Growth
To establish stable infection, Mycobacterium tuberculosis (MTb) must overcome host innate immune mechanisms, including those that sense pathogen-derived nucleic acids. Here, we show that the host cytosolic RNA sensing molecules RIG-I-like receptor (RLR) signaling proteins RIG-I and MDA5, their commo...
Saved in:
Published in | iScience Vol. 22; pp. 299 - 313 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
20.12.2019
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 2589-0042 2589-0042 |
DOI | 10.1016/j.isci.2019.11.001 |
Cover
Loading…
Summary: | To establish stable infection, Mycobacterium tuberculosis (MTb) must overcome host innate immune mechanisms, including those that sense pathogen-derived nucleic acids. Here, we show that the host cytosolic RNA sensing molecules RIG-I-like receptor (RLR) signaling proteins RIG-I and MDA5, their common adaptor protein MAVS, and the RNA-dependent kinase PKR each independently inhibit MTb growth in human cells. Furthermore, we show that MTb broadly stimulates RIG-I, MDA5, MAVS, and PKR gene expression and their biological activities. We also show that the oral FDA-approved drug nitazoxanide (NTZ) significantly inhibits intracellular MTb growth and amplifies MTb-stimulated RNA sensor gene expression and activity. This study establishes prototypic cytoplasmic RNA sensors as innate restriction factors for MTb growth in human cells and it shows that targeting this pathway is a potential host-directed approach to treat tuberculosis disease.
[Display omitted]
•MTb infection induces RNA sensor (RIG-I, MDA5, PKR) mRNA levels and activities•RIG-I, MDA5, MAVS, and PKR restrict intracellular MTb growth in human cells•NTZ enhances MTb-driven RNA sensor mRNA levels and RLR activities•NTZ and NTZ derivatives inhibit intracellular MTb growth in primary human cells
Biological Sciences; Immunology; Immune Response; Microbiology; Molecular Microbiology |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Lead Contact Present address: Profectus Biosciences, Pearl River, NY 10965, USA These authors contributed equally |
ISSN: | 2589-0042 2589-0042 |
DOI: | 10.1016/j.isci.2019.11.001 |